Valuation: Biogen Inc.

Capitalization 2.79TCr 2.38TCr 2.19TCr 2.07TCr 3.81TCr 2,61600Cr 3.9TCr 26TCr 10TCr 1,25300Cr 10TCr 10TCr 4,44800Cr P/E ratio 2026 *
16x
P/E ratio 2027 * 14.5x
Enterprise value 2.85TCr 2.43TCr 2.23TCr 2.11TCr 3.89TCr 2,67000Cr 3.98TCr 26TCr 10TCr 1,27900Cr 11TCr 10TCr 4,54000Cr EV / Sales 2026 *
3.01x
EV / Sales 2027 * 2.71x
Free-Float
85.5%
Yield 2026 *
-
Yield 2027 * -
1 day+2.22%
1 week+6.21%
Current month+3.68%
1 month+4.74%
3 months+10.11%
6 months+29.99%
Current year+8.00%
1 week 174.85
Extreme 174.85
192.75
1 month 168.64
Extreme 168.64
192.75
Current year 160.36
Extreme 160.3645
202.41
1 year 115.25
Extreme 115.25
202.41
3 years 110.04
Extreme 110.035
319.76
5 years 110.04
Extreme 110.035
468.55
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Chairman 66 26/06/2023
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Change 5d. change 1-year change 3-years change Capi.($)
+2.22%+6.21%+63.16%-35.35% 2.73TCr
-0.10%-1.18%+32.96%-6.76% 7.67TCr
-1.62%-10.16%+78.36%+177.19% 5.53TCr
-1.70%+56.10%+56.10%+56.10% 4.97TCr
-5.70%-6.44%-46.02%-57.19% 4.71TCr
+2.53%+5.22%+121.25%-60.53% 2.15TCr
+0.54%-0.97%+70.32%+29.70% 1.91TCr
-1.36%-1.17%+54.45%+52.71% 1.55TCr
-2.28%-4.48%+122.14%+368.77% 1.48TCr
-2.57%+1.84%-6.99%+678.14% 1.34TCr
Average -1.35%-1.07%+54.57%+120.28% 3.4TCr
Weighted average by Cap. -1.44%-1.89%+46.17%+67.57%

Financials

2026 *2027 *
Net sales 946.52Cr 808.6Cr 742.79Cr 701.09Cr 1.29TCr 89TCr 1.32TCr 8.72TCr 3.43TCr 43TCr 3.55TCr 3.48TCr 1,50900Cr 938.16Cr 801.46Cr 736.23Cr 694.9Cr 1.28TCr 88TCr 1.31TCr 8.64TCr 3.4TCr 42TCr 3.52TCr 3.45TCr 1,49600Cr
Net income 178.63Cr 152.6Cr 140.18Cr 132.31Cr 244.17Cr 17TCr 249.56Cr 1.65TCr 647.19Cr 8.02TCr 669.95Cr 655.99Cr 28TCr 204.75Cr 174.91Cr 160.68Cr 151.66Cr 279.87Cr 19TCr 286.05Cr 1.89TCr 741.81Cr 9.2TCr 767.89Cr 751.9Cr 33TCr
Net Debt 58Cr 50Cr 45Cr 43Cr 79Cr 5.44TCr 81Cr 533.86Cr 209.99Cr 2.6TCr 217.37Cr 212.85Cr 9.24TCr -245.19Cr -209.47Cr -192.42Cr -181.62Cr -335.15Cr -23TCr -342.55Cr -2.26TCr -888.33Cr -11TCr -919.57Cr -900.42Cr -39TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
22/26/22 190.07 $ +2.22% 13,27,708
21/26/21 185.95 $ +1.42% 10,63,303
20/26/20 183.34 $ +3.38% 14,84,371
17/26/17 177.35 $ +0.76% 12,39,458
16/26/16 176.02 $ -2.50% 9,53,722
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
190.07USD
Average target price
210.69USD
Spread / Average Target
+10.85%

Quarterly revenue - Rate of surprise